跳至主要内容
临床试验/NCT03212261
NCT03212261已完成不适用

Promoting Resiliency Among Lymphoma Survivors: The 3RP-Lymphoma

Massachusetts General Hospital2 个研究点 分布在 1 个国家目标入组 37 人开始时间: 2017年8月3日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
37
试验地点
2
主要终点
Program Feasibility: Number of Participants Who Completed at Least 75% of the Treatment Sessions

研究概览

简要总结

The Relaxation Response Resiliency Program (3RP) was developed by researchers at the MGH Benson-Henry Institute for Mind Body Medicine; This program has recently been adapted to target the needs of individuals who have completed treatment for lymphoma (3RP-Lymphoma).

详细描述

The Relaxation Response Resiliency Program, or 3RP, was developed by researchers at the MGH Benson-Henry Institute for Mind Body Medicine. The 3RP is a group program that-through a variety of mind-body approaches, such as imagery, relaxation, and yoga-seeks to buffer stress and promote psychological resiliency and physical well-being.

The 3RP has not yet been carried out with individuals who have recently completed treatment for lymphoma. As such, the investigators have adapted the standard 3RP program to target the specific needs of lymphoma patients who are transitioning off active treatment. The investigators are conducting this study to see if the adapted program, the 3RP-Lymphoma, is effective at reducing stress and stress-related symptoms for people who have completed treatment for lymphoma within the past two years. To develop the 3RP-Lymphoma, the investigators conducted interviews with patients who had recently completed treatment to learn about their experiences and their preferences for topics they would want to include in a program tailored to their specific needs. The current phase of the feasibility study will examine if the adapted program is feasible, acceptable, and helps promote stress management among lymphoma survivors who are in the early stages of completing cancer treatment.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 64 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Aged 18-64
  • Within 2 years post-treatment completion for lymphoma
  • English speaking
  • Able and willing to provide informed consent
  • Cancer treatment or follow-up for lymphoma at the MGH Cancer Center

排除标准

  • Unwilling or unable to participate in the study
  • Unable to speak or read English
  • Is medically, psychiatrically, or otherwise unable to participate (as determined by a physician or study PI)
  • Unwilling or unable to participate in group 3RP sessions delivered via the Partners Telehealth videoconferencing software
  • Participation in qualitative interview during Phase 1 (DF/HCC 16-396)

结局指标

主要结局

Program Feasibility: Number of Participants Who Completed at Least 75% of the Treatment Sessions

时间窗: 1 month after completing the 3RP-Lymphoma program

The investigators will evaluate program feasibility by examining rates of treatment completion. Participants who complete at least 75% of the treatment sessions will be identified as treatment completers.

Number of Participants Who Found the 3RP Program Acceptable

时间窗: 1 month after completing the 3RP-Lymphoma program

Acceptability will be assessed at the one-month follow up data collection period with five questions on the 3RP acceptability questionnaire rated on a 4-point Likert scale (1=not at all to 4=very much); higher scores mean higher levels of acceptability.

次要结局

  • Number of Participants Who Were Eligible to Provide and Provided Hair Cortisol Samples(1 month after completing the 3RP-Lymphoma program)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Giselle K. Perez Lougee

Instructor in Psychiatry at Harvard Medical School

Massachusetts General Hospital

研究点 (2)

Loading locations...

相似试验